StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4427.T$201.00-16.25%
Fair $201.00+0.0%

4427.T

EduLab, Inc.

Technology / Information Technology ServicesTokyo

$201.00

-39.00 (-16.25%)

Fairly Valued+0.0%Fair Value $201.00Fund rank 28/100 · Data gapFallback financials|
SA 26/D
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-150.1M · quality 53.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.2%, below the 5% threshold
Thesis & Journal · 4427.TLocal privado en este navegador · EduLab, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.1B

P/E

N/A

•

EV/EBITDA

5.9x

↓

ROE

1.2%

↓

Gross Margin

33.0%

↑

Debt/Equity

0.38

↑
52-Week Range$201
$187$559

TradingView lightweight chart

4427.T price, volumen y niveles de valoración

Último $201.00Periodo -94.6%
Fair value: $201.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-13.9%

FCF CAGR

—

FCF margin

-2.4%

FCF / Net income

-9.15x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.23B · net income $16.4M · FCF $-150.1M

2022-FY → 2025-FY

Gross margin

33.0%+2.4% pts

Operating margin

6.3%+8.7% pts

Net margin

0.3%+8.7% pts

FCF margin

-2.4%+14.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$6.23B$6.23B$7.14B$7.06B$9.76B
Net Income$16.4M$16.4M$-1.27B$-3.11B$-818.7M
EBITDA$200.1M$200.1M$-928.3M$-2.80B$-42.5M
EPS——-124.61-305.07-81.54
Gross Margin33.0%33.0%24.1%27.3%30.6%
Operating Margin6.3%6.3%-4.6%-7.7%-2.4%
Net Margin0.3%0.3%-17.8%-44.0%-8.4%
Balance Sheet
Debt/Equity0.380.380.481.251.02
Current Ratio1.961.96———
Cash Flow
Free Cash Flow$-150.1M$-150.1M$-1.53B$-26.0M$-1.69B
Returns
ROE1.2%1.2%-93.6%-169.6%-16.7%
Valuation
EV/EBITDA5.915.91———
P/B1.521.522.002.071.23
Growth & Yield
Revenue Growth-12.8%-12.8%1.1%-27.6%—
EPS Growth——59.2%-274.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -26.4%

Total return

-26.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-124.61 → n/d

Residual

-26.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-26.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.